Home › Cardiovascular Disease › Louisiana › Metairie
Cardiovascular Disease clinical trials in Metairie, LA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Metairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Metairie
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Omega Clinical Research, Metairie
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- Omega Clinical Research, Metairie
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Recruiting
- Poirot Podiatry, Metairie
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Metairie
- Prostate Cancer12 studies
- Ulcerative Colitis8 studies
- Bladder Cancer6 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
- Steatotic Liver Disease4 studies
- Metastatic Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Neuroendocrine Tumors3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.